Dr. Plevy is a gastroenterologist and molecular immunologist. He most recently served as chief scientific officer at biotechnology company Senda Biosciences and has previously held leadership positions at Janssen Pharmaceuticals and Synlogic Therapeutics. He has published more than 110 peer-reviewed papers on immunologic disorders, including those related to inflammatory bowel disease.
Dr. Plevy received his medical degree from Columbia University in New York City and completed his residency at Brigham and Women’s Hospital in Boston.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
